Encompass Health (EHC) Could Be 20% Undervalued As Rehab Expansion Builds Out - Yahoo Finance

Michael Douglas hit back at a decades-old rumor that he went to rehab for an alleged sex addiction during a strained interview published Sunday by the U. K.’s Sunday Times. Douglas, 82, was discussing his new memoir, “One Helluva Ride,” with British journalist Decca Aitkenhead. She reminded him that he wrote about having to break things off with five women before becoming monogamous with actor Catherine Zeta-Jones, whom he married in 2000 shortly after the end of his first marriage, to Diandra Luker. “No, no, it’s not what it was,” the actor told Aitkenhead of how he became monogamous with his now-wife. “What Catherine said is, if we’re going to continue this, then I want it to be monogamous. And so I therefore, that evening, you know, made some calls to some people I was seeing, and that was that.”In her article, Aitkenhead writes that Douglas then gives her an expression that “suggests that he thinks he’s just corrected me.” Actors Catherine Zeta-Jones and Michael Douglas got married on Nov. 18, 2000, the same year he finalized his divorce from his first wife, Diandra Luker.

Bioengineer.org news storyFor millions of people living with HIV, antiretroviral therapy has transformed a once-fatal infection into a manageable chronic condition. Yet the very drugs that suppress the virus can carry quiet costs, and one of the most insidious is bone loss. Tenofovir disoproxil fumarate, or TDF, has been a cornerstone of HIV treatment worldwide for two decades, prized for its potency, durability, and low cost. But a growing body of evidence has linked TDF exposure to measurable reductions in bone mineral density, raising an increasingly urgent clinical question: once bone has been lost on a TDF-based regimen, can it be recovered? A new prospective cohort study, published in BMC Infectious Diseases, offers some of the most detailed longitudinal evidence to date that the answer, for many patients, is yes. The research team enrolled 223 virologically suppressed men living with HIV who had low bone mineral density while taking TDF-based antiretroviral therapy.